ArticleScientific reports2026
Growth monitoring and promotion utilisation among children aged 24-59 months attending an Urban Health Centre in Malawi: prevalence and associated factors.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Growth monitoring and promotion (GMP) is a key strategy to prevent under nutrition in children under-five. However, GMP utilisation among children aged 24-59 months in Malawi remains low, with limited evidence on its determinants. This study assessed the prevalence and determinants of GMP utilisation among caregivers of children aged 24-59 months at Mzuzu Urban Health Centre, Malawi. A facility-based cross-sectional study was conducted from July to September 2022 among 387 caregivers attending under-five clinics at a single urban health centre in Malawi. Data were collected using an interviewer-administered questionnaire and verified using health passports. Multivariable logistic regression was used to identify factors associated with GMP utilisation. The prevalence of GMP utilisation was 39% (95% CI: 34-44%). Factors independently associated with GMP utilisation were children aged 24-35 months (AOR = 2.51; 95% CI: 1.55-4.05), caregiver age ≤ 35 years (AOR = 2.78; 95% CI: 1.33-5.79), secondary education (AOR = 1.77; 95% CI: 1.10-2.86), high GMP-related knowledge (AOR = 2.01; 95% CI: 1.23-3.27) receipt of nutrition counselling (AOR = 2.90; 95% CI: 1.70-4.98). GMP utilisation among caregivers of children aged 24-59 months attending this urban health facility was low, although general awareness of GMP was high. Utilisation was associated with child age, caregiver age, secondary education, GMP-related knowledge, and receipt of nutrition counselling. Targeted improvements in caregiver education, growth- chart interpretation support, and routine counselling may help strengthen GMP utilisation in similar facility-based settings in Malawi.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.